Keratinocyte-derived IL-7 has been described as a potent growth factor for CTCL [61–63], and regulation of its receptor IL7R has previously been associated with IL-2 cytokine signaling [64, 65]. This evidence concerns the gene IL7 and primary cutaneous T-cell non-Hodgkin lymphoma.